Lacosamida Teva (Lacosamide)

Lacosamida Teva is a sodium channel‑blocking antiepileptic used to manage focal seizure disorders.

• Partial‑onset seizures (focal seizures): Adjunctive therapy to reduce seizure frequency in epilepsy patients.
• Focal epilepsy: Improves overall seizure control when added to existing antiepileptic regimens.
• Refractory focal seizures: Provides additional seizure reduction for patients not adequately controlled by monotherapy.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, which stabilises hyper‑excitable neuronal membranes and diminishes repetitive neuronal firing. This selective modulation reduces the propagation of epileptic discharges without markedly affecting normal neuronal activity.

Lacosamida Teva may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects

• Dizziness: Transient sensation of light‑headedness or imbalance.
• Headache: Mild to moderate pain in the head region.
• Nausea: Stomach upset often occurring after dosing.
• Fatigue: Generalised tiredness or reduced energy.
• Diplopia: Temporary double vision.
• Somnolence: Increased sleepiness during the day.

Serious or Rare Side Effects

• Cardiac arrhythmia: Irregular heart rhythm requiring medical attention.
• Suicidal ideation: Thoughts of self‑harm that should be reported immediately.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Cardiac conduction abnormalities: PR‑interval prolongation on ECG.
• Hypersensitivity reactions: Anaphylaxis or severe allergic response.
• Hepatic dysfunction: Elevated liver enzymes or liver injury.

Before initiating therapy, several safety considerations should be reviewed.

• Renal impairment: Assess kidney function and adjust dosing if necessary.
• Hepatic impairment: Monitor liver enzymes and consider dose modification.
• Concomitant antiepileptics: Watch for additive central nervous system effects.
• Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus.
• Driving and operating machinery: Caution advised due to possible dizziness or somnolence.
• Store at ambient temperature: Keep below 25°C, protect from moisture and light.

Lacosamida Teva can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): May increase lacosamide plasma levels.
• Carbamazepine: May reduce lacosamide effectiveness.
• Other sodium channel blockers (e.g., phenytoin): Heightened risk of central nervous system depression.

Moderate Interactions (Monitor Closely)

• Additional antiepileptics (e.g., valproate): Monitor for additive side effects.
• Alcohol: May potentiate sedation and dizziness.
• Antihypertensives: Observe blood pressure for possible additive lowering effect.